Repligen (RGEN) Reiterated at Buy by Stifel on Strong 2027 Setup

November 2, 2026 7:19 AM EST Send to a Friend
Stifel analyst Daniel Arias reiterated a Buy rating and $207.00 price target on Repligen (NASDAQ: RGEN).The analyst commented, "We hosted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login